Humana, Inc. Hits New 52-Week High at $380.79, Reflecting Strong Growth

Humana, Inc. has reached a significant milestone by hitting a new 52-week high of USD 380.79 on June 15, 2026. This achievement underscores the company's strong position within the healthcare services industry, where it operates as a mid-cap entity with a market capitalization of USD 32,156 million. Over the past year, Humana's stock performance has shown an increase of 8.85%, although it lags behind the S&P 500's performance of 26.39%. The company's price-to-earnings (P/E) ratio stands at 27.00, indicating its valuation relative to earnings. Additionally, Humana offers a dividend yield of 1.60%, providing a return to its shareholders. Financial metrics such as a debt-to-equity ratio of -0.42 and a return on equity of 6.81% reflect the company's financial health and operational efficiency. The price-to-book ratio is recorded at 1.82, further illustrating its market valuation. As Humana continues to navigate the healthcare landscape, this new high marks a notable point in its financial journey.